Polyamyna Nanotech Inc.
PrivateLast Round
Debt
Nov 25, 2025
Total Funding Raised
$1.16M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Polyamyna Nanotech Inc. operates in Healthcare & Life Sciences and is based in St. John's. Its latest recorded funding round was a Grant round in October 2023.
Polyamyna Nanotech Inc. is a biotechnology company that develops antimicrobial coatings to prevent hospital-acquired infections and combat antimicrobial resistance.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Advanced Materials
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Polyamyna Nanotech Inc. Comparables
Compare Polyamyna Nanotech Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Kismet Technologies | 85% | |
| Allied BioScience | 85% | |
| Bio-Fence | 83% |
For institutional investors. Book with your work email.
Polyamyna Nanotech Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Nov 25, 2025 | ||||
| Grant | Oct 31, 2023 | ||||
| Grant | Dec 1, 2022 | ||||
| Grant | Oct 12, 2021 | ||||
| Pre Seed | May 13, 2021 | ||||
Accelerator | Jan 1, 2021 |
For institutional investors. Book with your work email.
Polyamyna Nanotech Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Government of Newfoundland and Labrador | Grant |
| National Research Council Canada Industrial Research Assistance Program | Grant |
| Atlantic Canada Opportunities Agency | Debt |
| National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) | Grant |
| Genesis Centre | Accelerator |
| National Research Council of Canada | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 20, 2026
Monthly visitors increased 76% MoM.
- Apr 20, 2026
Monthly visitors increased 703% MoM, from 172 to 1.4K.
For institutional investors. Book with your work email.
Polyamyna Nanotech Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Polyamyna Nanotech Inc.'s valuation, stock price, and market status.
Is Polyamyna Nanotech Inc. a public or private company?
Polyamyna Nanotech Inc. is a private company.
What is the current stock price of Polyamyna Nanotech Inc.?
Polyamyna Nanotech Inc. is a private company, so its shares have no public market price. Caplight tracks Polyamyna Nanotech Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Polyamyna Nanotech Inc. worth (valuation)?
Valuation information for Polyamyna Nanotech Inc. is not publicly available.
Can I buy Polyamyna Nanotech Inc. stock?
Polyamyna Nanotech Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Polyamyna Nanotech Inc.'s last funding round?
Polyamyna Nanotech Inc.'s most recent funding round was Debt on November 25, 2025.
Who are the main investors in Polyamyna Nanotech Inc.?
Key investors in Polyamyna Nanotech Inc. include Government of Newfoundland and Labrador, National Research Council Canada Industrial Research Assistance Program, Atlantic Canada Opportunities Agency, National Research Council of Canada Industrial Research Assistance Program (NRC IRAP), Genesis Centre.
Will Polyamyna Nanotech Inc. IPO soon?
No public IPO plans have been announced for Polyamyna Nanotech Inc..
How can I track Polyamyna Nanotech Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Polyamyna Nanotech Inc.'s shares on secondary markets.